Literature DB >> 27538831

The Role of UPC2 Gene in Azole-Resistant Candida tropicalis.

Cen Jiang1, Qi Ni1, Danfeng Dong1, Lihua Zhang1, Zhen Li1, Yuan Tian1, Yibing Peng2.   

Abstract

Azole resistance of Candida tropicalis has, in recent years, become a serious issue in hospitals; however, there is limited knowledge of the mechanisms underlying this resistance. We have previously demonstrated that ERG11 plays a vital role in azole resistance in C. tropicalis. Here, we describe the expression and sequence variation of UPC2, which encodes a transcription factor of ERG11. Quantitative real-time RT-PCR showed that 31 azole-resistant C. tropicalis strains significantly overexpressed UPC2. Those isolates resistant to all three azole antifungals upregulated UPC2 expression to a greater degree than those resistant to only fluconazole or itraconazole. The UPC2 promoter contains mutations -118T-G and -155G-A in azole-resistant strains of C. tropicalis. Meanwhile, the mutation G392E was also detected twice in UPC2 gene in azole-resistant C. tropicalis and was demonstrated to mediate azole antifungal susceptibility by using Saccharomyces cerevisiae as an expression host, particularly for fluconazole and itraconazole.

Entities:  

Keywords:  Antifungal resistance; Azole; Candida tropicalis; UPC2

Mesh:

Substances:

Year:  2016        PMID: 27538831     DOI: 10.1007/s11046-016-0050-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  18 in total

1.  cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.

Authors:  Brian G Oliver; Jia L Song; Jake H Choiniere; Theodore C White
Journal:  Eukaryot Cell       Date:  2007-10-19

2.  Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism.

Authors:  Peter M Silver; Brian G Oliver; Theodore C White
Journal:  Eukaryot Cell       Date:  2004-12

3.  Regulation of sterol metabolism in Candida albicans by the UPC2 gene.

Authors:  T C White; P M Silver
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

4.  Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.

Authors:  Sarah MacPherson; Bassel Akache; Sandra Weber; Xavier De Deken; Martine Raymond; Bernard Turcotte
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.

Authors:  Patrick Vandeputte; Guy Tronchin; Françoise Rocher; Gilles Renier; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

6.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

Review 7.  From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans.

Authors:  Bernhard Hube
Journal:  Curr Opin Microbiol       Date:  2004-08       Impact factor: 7.934

8.  The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.

Authors:  Christoph Sasse; Nico Dunkel; Tina Schäfer; Sabrina Schneider; Franziska Dierolf; Knut Ohlsen; Joachim Morschhäuser
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501

Review 9.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

10.  Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.

Authors:  João B A Neto; Cecília R da Silva; Maria A S Neta; Rosana S Campos; Janaína T Siebra; Rose A C Silva; Danielle M Gaspar; Hemerson I F Magalhães; Manoel O de Moraes; Marina D P Lobo; Thalles B Grangeiro; Tatiane S C Carvalho; Emilay B T Diogo; Eufrânio N da Silva Júnior; Felipe A R Rodrigues; Bruno C Cavalcanti; Hélio V N Júnior
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more
  6 in total

1.  Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis.

Authors:  Saikat Paul; Dipika Shaw; Himanshu Joshi; Shreya Singh; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Anup K Ghosh
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

Review 2.  Oxygen-responsive transcriptional regulation of lipid homeostasis in fungi: Implications for anti-fungal drug development.

Authors:  Risa Burr; Peter J Espenshade
Journal:  Semin Cell Dev Biol       Date:  2017-08-26       Impact factor: 7.727

Review 3.  From Lipid Homeostasis to Differentiation: Old and New Functions of the Zinc Cluster Proteins Ecm22, Upc2, Sut1 and Sut2.

Authors:  Ifeoluwapo Matthew Joshua; Thomas Höfken
Journal:  Int J Mol Sci       Date:  2017-04-05       Impact factor: 5.923

Review 4.  The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.

Authors:  Jingxiang Zhang; Liping Li; Quanzhen Lv; Lan Yan; Yan Wang; Yuanying Jiang
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

5.  MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.

Authors:  Longyang Jin; Zhuorui Cao; Qi Wang; Yichen Wang; Xiaojuan Wang; Hongbin Chen; Hui Wang
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

6.  Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression.

Authors:  Dan Wang; Na An; Yuwei Yang; Xianggui Yang; Yingzi Fan; Jiafu Feng
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-15       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.